DeGette's Loss: Mixed Bag for Drug Industry
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- DeGette's political loss is characterized as a "mixed bag" for the drug industry in STAT's D.C. Diagnosis newsletter
- The drug industry will lose a key Democratic lawmaker who was knowledgeable about the industry, "if not always a friend," according to the newsletter
Why it matters: Pharma loses a substantive Democratic voice on drug policy who understood the industry's technical details, even if not always a reliable ally — narrowing the bipartisan bench of lawmakers who can actually engage with pharmaceutical legislation on the merits.
